PHARMACOVIGILANCE AND REGULATORY ACTION IN EAST AFRICA WITH A FOCUS ON TANZANIA: A SCOPING REVIEW

  • Lambert Philipo Barugahale Kitete Regional Referral Hospital Tabora, Tanzania.
  • Sechelela Vincent Lemanya Kitete Regional Referral Hospital Tabora, Tanzania.
  • Kennedy John Ndetico Kitete Regional Referral Hospital Tabora, Tanzania.
  • Lewis Mwombeki Kitete Regional Referral Hospital Tabora, Tanzania.
10.22270/ujpr.v11i5.1671

Keywords:

adverse drug reaction, East Africa, medicine safety, meta-analysis, pharmacovigilance, regulatory action, Tanzania

Abstract

Background: Pharmacovigilance (PV) detects, assesses and prevents adverse drug reactions (ADRs) and other medicine-related problems. East African countries have built national PV systems, but underreporting and the weak visibility of links between safety information and regulatory decisions persist.

Objectives: To map evidence on PV systems and regulatory action in East Africa with emphasis on Tanzania; to quantify key PV outcomes among health professionals; to identify factors associated with ADR reporting; and to describe how safety information is translated into regulatory action.

Methods: Rapid scoping review following the Arksey and O’Malley framework, Joanna Briggs Institute guidance and PRISMA-ScR reporting, with a conditional quantitative synthesis. Targeted searches of web-indexed biomedical literature, repositories and regulatory and media sources were run in October 2026.

Results: Twenty-five sources were charted: 17 research sources (Tanzania, Uganda, Kenya, Ethiopia, Rwanda and two multi-country studies) and eight regulatory, programme and media reports. In 2017/18, spontaneous reporting was 4.1 reports per million inhabitants in mainland Tanzania, 6.7 in Ethiopia and 35.0 in Kenya, and no more than 1% of facilities submitted reports. Nine surveys of health professionals (n=3,091) gave a pooled ADR-reporting proportion of 30.3% (95% CI 19.1–44.4%; I²=97.9%; 95% prediction interval 4.3–81.0%).

Conclusions: PV structures have advanced and reporting can be raised sharply by training and stimulated reporting, but low and uneven reporting, training gaps and limited visibility of locally triggered regulatory action constrain medicine safety.

                 

Peer Review History:

Received 25 July 2026;   Reviewed 3 September 2026; Accepted  8 October; Available online 15 November 2026

Academic Editor: Dr. Jennifer Audu-Peterorcid22.jpg, University of Jos, Nigeria, [email protected]

Reviewers:

orcid22.jpgDr. Noha El Baghdady, MTI University, Cairo, Egypt, [email protected]

orcid22.jpgDr. Mayada M. El-Azab, Phytochemistry Unit, Department of Medicinal and Aromatic Plants, Desert Research Center, Cairo, Egypt. [email protected]

Downloads

Download data is not yet available.
Crossmark
Statistics
19 Views | 37 Downloads
Dimension Citations

Published

2026-11-15

How to Cite

Lambert Philipo Barugahale, Sechelela Vincent Lemanya, Kennedy John Ndetico, and Lewis Mwombeki. “PHARMACOVIGILANCE AND REGULATORY ACTION IN EAST AFRICA WITH A FOCUS ON TANZANIA: A SCOPING REVIEW”. Universal Journal of Pharmaceutical Research, vol. 11, no. 5, Nov. 2026, doi:10.22270/ujpr.v11i5.1671.

Issue

Section

Review Articles